Treatment for Myeloproliferative Disorders

A Sneak Peek of Our Coverage on MDM2 Inhibition

Cancer researchers identified a promising new target for inhibitor treatment in MPNs – MDM2 – which may allow the cancer cell suppressor gene P53 to reactivate. Watch now to learn more.

Published:

Prioritizing Patients: Dr. Pemmaraju’s MPN Highlights From ASCO 2019

How are researchers going beyond the breakthroughs in cancer care? Watch as Dr. Naveen Pemmaraju discusses MPN treatment developments from ASCO 2019.

Published:

Key Tips on How to Approach MPN Treatment Decisions

How can patients feel confident about their MPN care? Watch as MPN expert Dr. Srdan Verstovsek and patient advocates share advice for approaching treatment decisions.

Published:

Will CAR T-Cell Therapy Work for Solid Tumor Cancers?

Is CAR T-cell therapy on the horizon for patients with solid tumor cancers? Watch as Dr. David Maloney discusses advances in CAR-T research, current clinical studies, treatment efficacy and more.

Published:

Patient Advocate Bob Klein Shares What's Ahead in Stem Cell Research and New Treatments for Chronic Illnesses

Bob Klein was inspired by his own family - wife with cancer, son with type 1 diabetes and mom with Alzheimer’s - to help others. Watch as he discusses initiatives to raise funds for stem cell research and more.

Published:

Woman With Myelofibrosis Gets Unapproved Drug With Help of Care Team

How can you advocate for yourself with a clinical trial drug if it’s later taken away? Watch as Sandra Dillon shares her story of her fedratinib trial.

Published:

Transplant vs. Oral Medication for MPNs: How Can You Decide Which Is the Right Fit?

What factors should patients consider when contemplating transplant vs. oral therapy? Watch as Dr. Srdan Verstovsek and Samantha Trahan discuss the risks and benefits of MPN treatments.

Published:

Following MPN Disease Evolution: A Patient-Physician Approach to Monitoring Change and Adjusting Treatment Plans

Dr. Srdan Verstovsek and patient advocate Samantha Trahan give insight into a teamwork approach to MPN care. Watch as they discuss prognostic markers, MPN progression and more.

Published:

What Do Mutations Indicate About Disease Behavior in MPNs?

Can genetic mutations can predict how aggressive MPNs will be or indicate a poor treatment response? Tune in to hear MPN expert Dr. Joseph Scandura explain mutational status.

Published:

Showing 9 of 188 programs
Advertisement
Join Our Community Register for Events Read Our Latest Blog
Advertisement

Page last updated on June 19, 2019